Trinity Biotech (TRIB) FCF Margin (2009 - 2024)
Trinity Biotech's (TRIB) quarterly FCF Margin came in at 23.59% in Q4 2024, up 1942.0% year-on-year from 1.16% in Q1 2024, and up 195.43% quarter-over-quarter from 24.72% in Q2 2024.
Trinity Biotech (TRIB) FCF Margin (2009 - 2024) Analysis & Trends
Trinity Biotech has disclosed FCF Margin across 6 years of filings, most recently posting 23.59% for Q4 2024.
- FCF Margin for Q4 2024 came in at 23.59%, up 1942.0% year-over-year; the trailing twelve-month figure through Dec 2024 was 0.29% (up 1105.0% YoY), and the FY2025 annual result was 12.95%, down 549.0% from the prior year.
- FCF Margin came in at 23.59% for Q4 2024 at Trinity Biotech, up from 24.72% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 23.59% in Q4 2024 to a low of 51.29% in Q2 2023.
- The 4-year median for FCF Margin is 0.44% (2021), against an average of 0.41%.
- Across the five-year window, FCF Margin plunged 5129 bps in 2023 and jumped 2658 bps in 2024, its largest moves.
- Trinity Biotech's FCF Margin stood at 22.94% in 2021, then declined by 23 bps to 17.56% in 2022, then slumped by 76 bps to 4.17% in 2023, then jumped by 466 bps to 23.59% in 2024.
- The last three FCF Margin figures came in at 23.59% (Q4 2024), 24.72% (Q2 2024), and 0.02% (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 23.59% |
| Jun 30, 2024 | -24.72% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | 4.17% |
| Sep 30, 2023 | 0.87% |
| Jun 30, 2023 | -51.29% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | 17.56% |
| Sep 30, 2022 | 2.04% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 22.94% |
| Jun 30, 2021 | 0.00% |
| Sep 30, 2010 | 8.08% |
| Jun 30, 2010 | 4.91% |
| Mar 31, 2010 | 8.01% |
| Dec 31, 2009 | 7.76% |
| Sep 30, 2009 | 5.05% |
| Jun 30, 2009 | 5.84% |
| Mar 31, 2009 | 8.04% |